A 3d printer generates custom dental implants.

FDA Compliance for Custom Dental Implants & Prosthetics

Apr 5, 2025

Written by Marco Theobold


Custom dental implants & prosthetics—including titanium & zirconia implants, crowns, bridges & full-arch prosthetics—are becoming increasingly common in modern dentistry. While these devices are often patient-specific, they are still considered medical devices by the FDA & require regulatory compliance. Manufacturers must ensure that their products meet classification, premarket submission & postmarket monitoring requirements to avoid Import Alerts, detentions & enforcement actions.

How the FDA Classifies Custom Dental Implants

Understanding the FDA’s classification system is essential to determining the proper regulatory pathway:

Device Classifications

  • Class II (Moderate Risk): Includes prefabricated titanium & zirconia implants, abutments & bridges. These require 510(k) clearance to demonstrate equivalence to an FDA-cleared predicate device.
  • Class III (High Risk): Covers custom implants incorporating new materials or biologics. These require Premarket Approval (PMA) due to increased risk & the need for clinical data.
  • Exemptions: Some truly individualized custom devices may qualify under the Custom Device Exemption (CDE), but manufacturers must meet strict limits (e.g., five units per year) & reporting criteria.

Steps to Legally Market Custom Dental Implants in the US

To enter the US market, manufacturers must complete the following steps:

  • Establishment Registration: Annual FDA registration is required for all manufacturers & importers.
  • Medical Device Listing: Each implant or prosthetic must be listed under the registered facility.
  • 510(k) vs. PMA Submission: Most implants require 510(k), but new materials or regenerative functions may trigger PMA.
  • Biocompatibility Testing: Compliance with ISO 10993 ensures long-term safety.
  • Sterility Validation: Sterile implants must meet FDA sterility standards.

Common Compliance Challenges & Solutions

Even experienced manufacturers can face regulatory hurdles. These case studies highlight the importance of accurate classification & documentation:

Case Study: Titanium Implant Supplier Detained Due to Missing 510(k) Clearance

A custom titanium implant manufacturer faced import detention after failing to secure 510(k) clearance. The company had to:

  • Provide equivalence data linking its device to an approved predicate.
  • Redo mechanical & biocompatibility testing.
  • Work with consultants to prepare a compliant 510(k) submission.

Case Study: Custom Implant Manufacturer Misclassified as Exempt

A zirconia implant manufacturer misapplied the Custom Device Exemption. Producing more than five units annually triggered FDA enforcement:

  • The company experienced launch delays & regulatory penalties.
  • A 513(g) request was filed to clarify classification.
  • Product listings were resubmitted & 510(k) clearance obtained.

Regulatory Considerations for Custom Implant Manufacturers

Key compliance areas to monitor:

  • FDA User Fees: Required annually, with Small Business Fee Assistance available.
  • Import Alerts: Repeated noncompliance may lead to automatic detention.
  • Certificate to Foreign Government (CFG): Needed for exports.
  • Health Canada Licensing: An MDEL may be required for Canadian expansion.

Maintaining Compliance After Market Entry

FDA approval is just the beginning. Ongoing obligations include:

  • Electronic Medical Device Reporting (eMDR): All adverse events must be reported.
  • FOIA Requests: Help benchmark similar product approvals.
  • Medical Device Master File: Protects proprietary formulations & streamlines new submissions.
  • Ongoing Regulatory Consulting: Keeps your compliance efforts aligned with evolving FDA policies.

Building a Strong Foundation for Regulatory Success

Bringing custom dental implants & prosthetics to the US market requires strategic planning, accurate classification & ongoing compliance. Manufacturers that stay proactive with documentation, testing, labeling & postmarket tracking avoid costly delays & gain a long-term competitive edge.

Author


Marco Theobold

A highly regarded expert in medical device and drug regulations by the U.S. Food & Drug Administration (FDA), Marco brings a unique perspective for medical device and drug companies seeking to distribute products in the United States. He proudly provides guidance on FDA regulations for pharmaceutical, medical device, and radiation emitting device (RED) companies.

Related Article


Subscribe To Our News Feed

To top
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.